157 related articles for article (PubMed ID: 12431797)
1. Growth factors and human pituitary adenomas.
Spada A; Lania A
Mol Cell Endocrinol; 2002 Nov; 197(1-2):63-8. PubMed ID: 12431797
[TBL] [Abstract][Full Text] [Related]
2. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
3. [Genetic changes in human pituitary adenomas].
Spada A; Lania A
Minerva Endocrinol; 2003 Mar; 28(1):27-37. PubMed ID: 12621361
[TBL] [Abstract][Full Text] [Related]
4. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene.
Peri A; Conforti B; Baglioni-Peri S; Luciani P; Cioppi F; Buci L; Corbetta S; Ballaré E; Serio M; Spada A
J Clin Endocrinol Metab; 2001 May; 86(5):2111-7. PubMed ID: 11344215
[TBL] [Abstract][Full Text] [Related]
6. G protein abnormalities in pituitary adenomas.
Spada A; Lania A; Ballarè E
Mol Cell Endocrinol; 1998 Jul; 142(1-2):1-14. PubMed ID: 9783897
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of stimulatory G protein alpha-subunit is a hallmark of most human somatotrophic pituitary tumours and is associated with resistance to GH-releasing hormone.
Hamacher C; Bröcker M; Adams EF; Lei T; Fahlbusch R; Buchfelder M; Derwahl M
Pituitary; 1998 Apr; 1(1):13-23. PubMed ID: 11081179
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.
Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG
J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759
[TBL] [Abstract][Full Text] [Related]
9. Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas.
Lania A; Persani L; Ballaré E; Mantovani S; Losa M; Spada A
J Clin Endocrinol Metab; 1998 May; 83(5):1624-8. PubMed ID: 9589667
[TBL] [Abstract][Full Text] [Related]
10. GNAS imprinting and pituitary tumors.
Mantovani G; Lania AG; Spada A
Mol Cell Endocrinol; 2010 Sep; 326(1-2):15-8. PubMed ID: 20398730
[TBL] [Abstract][Full Text] [Related]
11. Signalling pathway alterations in pituitary adenomas: involvement of Gsalpha, cAMP and mitogen-activated protein kinases.
Pertuit M; Barlier A; Enjalbert A; Gérard C
J Neuroendocrinol; 2009 Nov; 21(11):869-77. PubMed ID: 19732293
[TBL] [Abstract][Full Text] [Related]
12. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
Shi Y; Tang D; Deng J; Su C
Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
[TBL] [Abstract][Full Text] [Related]
13. Genetics of pituitary tumors: Focus on G-protein mutations.
Lania A; Mantovani G; Spada A
Exp Biol Med (Maywood); 2003 Oct; 228(9):1004-17. PubMed ID: 14530508
[TBL] [Abstract][Full Text] [Related]
14. Gps mutations in Chilean patients harboring growth hormone-secreting pituitary tumors.
Johnson MC; Codner E; Eggers M; Mosso L; Rodriguez JA; Cassorla F
J Pediatr Endocrinol Metab; 1999; 12(3):381-7. PubMed ID: 10821217
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas.
Lania A; Mantovani G; Ferrante E; Zavanone LM; Locatelli M; Corbetta S; Beck-Peccoz P; Spada A
J Endocrinol Invest; 2004 Apr; 27(4):328-33. PubMed ID: 15233551
[TBL] [Abstract][Full Text] [Related]
16. Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors.
Mantovani G; Bondioni S; Lania AG; Corbetta S; de Sanctis L; Cappa M; Di Battista E; Chanson P; Beck-Peccoz P; Spada A
J Clin Endocrinol Metab; 2004 Jun; 89(6):3007-9. PubMed ID: 15181091
[TBL] [Abstract][Full Text] [Related]
17. Cellular alterations in pituitary tumors.
Spada A; Vallar L; Faglia G
Eur J Endocrinol; 1994 Jan; 130(1):43-52. PubMed ID: 7907260
[TBL] [Abstract][Full Text] [Related]
18. [Pituitary adenoma: mechanisms of endocrine oncogenesis].
Bertherat J; Bertagna X
Rev Prat; 1996 Jun; 46(12):1473-81. PubMed ID: 8881160
[TBL] [Abstract][Full Text] [Related]
19. Impact of gsp oncogene on the expression of genes coding for Gsalpha, Pit-1, Gi2alpha, and somatostatin receptor 2 in human somatotroph adenomas: involvement in octreotide sensitivity.
Barlier A; Pellegrini-Bouiller I; Gunz G; Zamora AJ; Jaquet P; Enjalbert A
J Clin Endocrinol Metab; 1999 Aug; 84(8):2759-65. PubMed ID: 10443675
[TBL] [Abstract][Full Text] [Related]
20. GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24.
Yamasaki H; Mizusawa N; Nagahiro S; Yamada S; Sano T; Itakura M; Yoshimoto K
Clin Endocrinol (Oxf); 2003 Apr; 58(4):464-70. PubMed ID: 12641630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
